Alterations in cell cycle control during tumor progression: Effects on apoptosis and the response to therapeutic agents

Current Topics in Microbiology and Immunology

Volumn 213 II, Issue , 1996, Pages 197-213

  Muschel, R J ^a   Mckenna, W G ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CYCLINE; PENTOXIFYLLINE; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; DNA DAMAGE; ETIOLOGY; HUMAN; METASTASIS; PRIORITY JOURNAL; REVIEW;

EID: 0029940978     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-61109-4_9     Document Type: Review

References (110)

1. Agarwal ML, Agarwal A, Taylor WR, Stark GR (1995) p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci USA 92: 8493-8497
2. Aloni-Grinstein R, Schwartz D, Rotter V (1995) Accumulation of wild type p53 protein upon gamma irradiation induces a G2 arrest-dependent immunoglobulin kappa light chain gene expression. EMBO J 14: 1392-1401
3. Amati B, Land H (1994) Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death Curr Biol 4: 102-108
4. Amati A, Littlewood TD, Evan GI, Land H (1993) The c-myc protein induces cell cycle progression and apoptosis through dimerization with Max EMBO J 12: 5083-5087
5. Bernhard EJ, Maity A, Muschel RJ, McKenna WG (1994) Increased expression of cyclin B1 mRNA coincides wirth diminished G2-phase arrest in irradiated HeLa cells treated with staurosporine or caffeine. Radiat Res 140: 393-400
6. Bernhard EJ, Muschel RJ, Bakanauskas VJ, McKenna WG (1996) Reducing the radiation-induced G2 delay causes HeLa cells to undergo apoptosis instead of mitotic death. Int J Radiat Biol (in press)
7. Bosch F, Jares P, Campo E, Lopez-Guillermo A, Piris M, Villamor N, Tassies D, Jaffe E, Montserrat E, Rozman C, Cardesa A (1994) PRAD-1/Cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood 84. 2726-2732
8. Busse P, Bose S, Jones R, Tolmach L (1977) The action of caffeine on X-irradiated HeLa cells II. Synergistic lethality. Radiat Res 71: 666-667
9. Callender T, el-Naggar A, Lee M, Frankenthaler R, Luna M, Batsakis J (1994) PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer 74: 152-158
10. Cheng J, Jhanwar S, Klein W, Bell D, Lee W-C, Altomare D, Nobori T, Olopade O, Buckler A, Testa J (1994) p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res 54: 5547-5551
11. Deng G, Zhang P, Harper JW, Elledge SJ, Leder P (1995) Mice lacking p21 cip1/waf1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675-684
12. Desai D, Wessling H, Fisher R, Morgan D (1995a) Effects of phosphorylation by CAK on cyclin binding by cdc2 and cdk2. Mol Cell Biol 15. 345-350
13. Desai D, Wessling H, Fisher R, Morgan D (1995b) Effects of phosphorylation by CAK on cyclin binding by CDC2 and CDK2. Mol Cell Biol 15: 345-350
14. Doree M, Galas S (1994) The cyclin-dependent protein kinases and the control of cell division. FASEB J 8: 1114-1121
15. Dynlacht B, Flores O, Lees J, Harlow E (1994) Differential regulation of E2F transactivation by cyclin/ cdk2 complexes. Genes Dev 8 1772-1786
16. Eilers M, Schirm S, Bishop JM (1991) The myc protein activates transcription of the alpha-prothymosin gene. EMBO J 10. 133-141
17. el-Deiry W, Tokino T, Velculescu V, Levy D, Parson R, Trent J, Lin D, Mercer W, Kinzler K, Vogelstein B (1993) WAF1, a potential mediator of p53 tumor supression. Cell 75: 817-825
18. Evan GI, Littlewood TD (1993) The role of c-myc in cell growth. Curr Opin Genet Dev 3: 44-49
19. Evan GI, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC (1992) Induction of apoptosis in fibroblasts by c-myc protein Cell 69 119-128
20. Fan SJ, Smith ML, Rivet DJ, Duba D, Zhan QM, Kohn KW, Fornace AJ, O'Connor PM (1995) Disruption of p53 function sensitizes breast cancer MCF7 cells to cisplatin and pentoxtfylline. Cancer Res 55: 1649-1654
21. Fornace A, Alamo I, Hollander M (1989a) DNA damage-inducible transcripts in mammalian cells. Proc Natl Acad Sci USA 85. 8800-8804
22. Fornace A, Nebert D, Hollander M, Leuthy J, Papathanasiou M, Fargnoli J, Holbrook N (1989b) Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents. Mol Cell Biol 9: 4196-4203
23. Gould K, Moreno S, Owen D, Sazer S, Nurse P (1991) Phosphorylation at thr 167 is required for schizosaccharomyces pombe p34cdc2 function. EMBO J 10: 3297-3309
24. Guillouf C, Rosselli F, Krishnaraju K, Moustacchi E, Hoffman B, Liebermann DA (1995) p53 involvement in control of G2 exit of the cell cycle: role in DNA damage-induced apoptosis. Oncogene 11: 2263-2270
25. Hannon GJ, Beach D (1994) p15 (INK48) is a potential effector of TGF-beta induced cell cycle arrest. Nature 371: 257-261
26. Harper JW, Adami GR, Wei N, Keyomarcki K, Elledge SJ (1993) The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin dependent kinases Cell 75: 805-816
27. Harrington EA, Bennett MR, Fanidi A, Evan GI (1994a) c-Myc-induced apoptosis in fibroblasts in inhibited by specific cytokines EMBO J 13: 3286-3295
28. Harrington EA, Fanidi A, Evan GI (1994b) Oncogenes and cell death. Curr Opin Gene Dev 4: 120-129
29. He J, Allen J, Collins V, Allalunisturner M, Godbout R, Day R, James C (1994) Cdk4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell-lines Cancer Res 54: 5804
30. Heikkila R, Schwab G, Wickstrom E, Loke S, Pluznik D, Watt R, Neckers L (1987) A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1. Nature 328: 445-449
31. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75: 241-251
32. Hunter T, Pines J (1994) Cyclins and cancer II: cyclin D and CDK inhibitors come of age Cell 79: 573-582
33. Hussussian C, Struewing J, Goldstein A, Higgins P, Ally D, Sheahan M, Clark W, Tucker M, Dracopoli N (1994) Germline p16 mutations in familial melanoma Nature Genet 8: 15-21
34. Igaki H, Sasaki H, Kishi T, Sakamoto H, Tachimori Y, Kato H, Watanabe H, Sugimura T, Terada M (1994) Highly frequent homozygous deletion of the p16 gene in estophageal cancer cell lines. Biochem Biophys Res Commun 203 1090-1095
35. Jen J, Harper J, Bigner S, Bigner D, Papadopoulos N, Markowitz S, Willson J, Kinzler K, Vogelstein B (1994) Deletion of p16 and p75 genes in brain tumors Cancer Res 54: 6353-6358
36. Jiang H, Lin J, Su Z, Collart F, Huberman E, Fisher P (1994) Induction of differentiation in human promyelocytic HL-60 leukemia cell activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9: 3397-3406
37. Kamb A, Gruis N, Weaverfeldhaus J et al. (1994a) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440
38. Kamb A, Shattuckeidens D, Eeles R et al. (1994b) Analysis of the p16 gene (cdkn2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genet 8. 22-26
39. Kane DJ, Safafian TA, Anton R, Hahn H, Gralla EB, Valentine JS, Ord T, Bredesen DE (1993) Bcl-2 inhibition of neural death decreased generation of reactive oxygen species. Science 262: 1274-1277
40. Kastan M, Zhan Q, el-Deiry W, Carrier F, Jacks T, Walsh W, Plunkett B, Vogelstein B, Fornace A (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71. 587-597
41. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304-6311
42. Kato J-Y, Matusushime H, Hiebert S, Ewen M, Sherr C (1993) Direct binding of cyclin D to the retinoblastoma gene product (PRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev 7: 331-342
43. Keyomarsi K, Pardee A (1993) Redundant cyclin overexpressson and gene amplification in breast cancer cells Proc Natl Acad Sci USA 90: 1112-1116
44. King RW, Jackson PK, Kirschner MW (1994) Mitosis in transition. Cell 79 563-570
45. Krek W, Marks J, Schmitz N, Nigg E, Simanis V (1992) Vertebrate p34cdc2 phosphorylation site mutants effects upon cell cycle progression in the fission yeast Schizosaccharomyces pombe J Cell Sci 102 43-53
46. Krek W, Nigg E (1991) Differential phosphorylation of vertebrate p34cdc2 kinase at the G1/S and G2/M transitions of the cell cycle: identification of major phosphorylation sites EMBO J 10: 305-316
47. Kuerbitz S, Plunkett B, Walsh W, Kastan M (1992) Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 89 7491-7495
48. Lane DP (1992) p53, guardian of the genome. Nature 358. 15-16
49. Lane DP (1993) A death in the life of p53 Nature 362: 786
50. Leach R, Elledge S, Sherr C, Willson J, Markowitz S, Kinzler K, Vogenstein B (1993) Amplification of cyclin genes in colorectal carcinomas. Cancer Res 53: 1986-1989
51. Lebwoh D, Muise-Helmericks R, Sepp-Lorenzino L, Serve S, Timaul M, Bol R, Borgen P, Rosen N (1994) A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line. Oncogene 9: 1925-1929
52. Li R, Waga S, Hannon G, Beach D, Stillman B (1994) Differential effects by the p21 inhibitor on PCNA-dependent DNA replication and repair Nature 37: 534-537
53. Li Y, Nichols M, Shay J, Xiong Y (1994) Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res 54: 6078-6082
54. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tlsty TD (1992) Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70: 923-935
55. Lock R (1992) Inhibition of p34 cdc2 kinase activation, tyrosine dephosphorylation, and mitotic progression in Chinese hamster ovary cells exposed to etoposide. Cancer Res 52: 1817-1822
56. Lorca T, Labbe J, Devault A, Fesquet D, Capony J, Cavadore J, Bouffant FL, Doree M (1992) Dephosphorylation of cdc2 on threonine 161 is required for cdc2 kinase inactivation and normal anaphase. EMBO J 11: 2381-2390
57. Lowe S, Schmitt E, Smith S, Osborne B, Jacks T (1993) P53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849
58. Maity A, McKenna WG, Muschel RJ (1994) Posttranscriptional regulation of cyclin B1 mRNA through the cell cycle and after irradiation EMBO J 14: 603-609
59. Michieli P, Chedid M, Lin D, Pierce J, Mercer W, Givol D (1994) Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 54: 3391-3395
60. Morgan D (1995) Principles of CDK regulation. Nature 374. 131
61. Morgenbesser SD, Williams BO, Jacks T, Depinho RA (1994) p53 dependent apoptosis produced by rb deficiency in the developing mouse lens. Nature 371: 72-74
62. Motokura T, Bloom T, Kim H, Juppner H, Ruderman J, Kronenberg H, Arnold A (1991) A novel cyclin encoded by a bell-linked candidate oncogene. Nature 350: 512-515
63. Muschel R, Zhang H, Iliakis G, McKenna W (1991) Cyclin B expression in HeLa cells during the G2 block induced by ionizing radiation. Cancer Res 51: 5113-5117
64. Muschel R, Zhang H, McKenna W (1993) Differential effect of ionizing radiation on the expression of cyclin A and cyclin B in Hela cells. Cancer Res 53 1-8
65. Muschel R, Bernhard E, Garza L, McKenna W, Koch C (1995) Induction of apoptosis at different oxygen tensions:evidence that oxygen radicals do not mediate apoptotic signalling. Cancer Res 55: 995-998
66. 1 to complete the cell cycle. Proc Natl Acad Sci USA 91: 8022-8026
67. Norbury C, Nurse P (1992) Animal cell cycles and their control. Annu Rev Biochem 61: 441-470
68. Nunez G, Seto M, Seremetis S, Ferrero D, Grignani F, Korsmeyer S, Favera RD (1989) Growth and tumor promoting effects of deregulated bcl2 in human B-lymphoblastoid cells Proc Natl Acad Sci USA 86: 4589-4593
69. O'Connor PM, Ferris DK, White GA, Pines J, Hunter T, Longo DL, Kohn KW (1992) Relationships between cdc2 kinase, DNA cross-linking, and cell cycle perturbations induced by nitrogen mustard. Cell Growth Differ 3: 43-52
70. O'Connor PM, Ferris DK, Pagano M, Draetta G, Pines J, Hunter T, Longo DL, Kohn KW (1993) G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently. J Biol Chem 268 8298-8308
71. O'Connor PM, Ferris DK, Hoffman I, Jackman J, Draetta G, Kohn KW (1994) Role of the cdc25C phosphatase in G2 arrest induced by nitrogen mustard in human lymphoma cells. Proc Natl Acad Sci USA 91. 9480-9484
72. Ogawa S, Hirano N, Sato N, Takahashi T, Hangaishi A, Tanaka K, Kurokawa M, Tanaka T, Mitani K, Yazaki Y, Hirai H (1994) Homozygous loss of the cyclin-dependent kinase 4-inhibitor (P16) gene in human leukemias. Blood 84 2431-2435
73. ink4 in human cancer Proc Natl Acad Sci USA 91 11045-11049
74. Oren M (1992) The involvement of oncogenes and tumor suppressor genes in the control of apoptosis. Cancer Metastasis Rev 11: 141-148
75. Osteen K, Rodgers W, Gaire M, Hargrove J, Gorstein F, Matrisian L (1994) Stromalepithelial interaction mediatesteroidal regulation of metalloproteinase expression in human endometrium. Proc Natl Acad Sci USA 91: 10129-10133
76. Otterson G, Kratzke R, Coxon A, Kim Y, Kaye F (1994) Absence of p16ink4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene 9: 3375-3378
77. Palayoor S, Macklis R, Bump E, Coleman C (1995) Modulation of radiation-induced apoptosis and G(2)M block in murine T-lymphoma cells Radiat Res 141: 235-243
78. Pan HC, Griep AE (1994) Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice-implications for tumor-suppressor gene function in development. Genes Dev 8: 1285-1299
79. Kip1: a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest Genes Dev 8: 9-22
80. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78 59-66
81. Powell SN, Defrank JS, Connell P, Edgan M, Preffer F, Dombkowski D, Tang W, Friend S (1995) Differential sensitivity of p53-and p53+ cells to caffeine-induced radiosensitization and override of G (2) delay. Cancer Res 55: 1643-1648
82. Reed JC (1994) Mini-review cellular mechanisms of disease series. J Cell Biol 124: 1-6
83. Reed J, Cuddy M, Haldar S, Croce C, Nowell P, Makover D, Bradley K (1990) Bcl-2-mediated tumongenicity of a human T-lymphoid cell line: synergy with myc and inhibition by bc12 antisense. Proc Natl Acad Sci USA 87: 3660-3664
84. Resnitzky D, Gossen M, Bujard H, Reed S (1994) Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system Mol Cell Biol 14: 1669-1679
85. Russell KJ, Wiens LW, Demers GW, Galloway DA, Plon SE, Groudine M (1995) Abrogation of the G(2) checkpoint results in differential radiosensitization of G(1) checkpoint deficient and G(1) checkpoint-competent cells. Cancer Res 55: 1639-1642
86. Schmidt E, Ichimura K, Reifenberger G, Collins V (1994) CDKN2 (p16/MTS1) gene deletion of CDK4 amplification occurs in the majority of glioblastomas. Cancer Res 54: 6321-6324
87. Serrano M, Hannon G Beach D (1993) A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704
88. Sheikh M, Li X-S, Chen J-C, Shao Z-M, Ordonez J, Fontana J (1994) Mechanisms of regulation of WAF1/ Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. Oncogene 9: 3407-3415
89. 1 cyclins. Cell 73: 1059-1065
90. Sherr C (1994) G1 phase progression: cycling on cue. Cell 79: 551-555
91. Shibuya H, Yoneyama M, Ninomiya-Tsuji J, Matsumoto K, Taniguchi T(1992) IL-2 and EGF receptors stimulate the homatopoietic cell cycle via different signaling pathways: demonstration of a novel role for c-myc. Cell 70. 57-67
92. Shirodkar S, Ewen M, DeCapro J, Morgan J, Livingston D, Chittenden T (1992) The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell 68: 157-166
93. Sicinski P, Donaher JL, Parker SB, Li TS, Gardner H, Haslam SZ, Bronson RT, Elledge SJ, Weinberg RA (1995) Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82: 621-630
94. Slingerland J, Hengst L, Pan G-H, Alexander D, Stampfer M, Reed S (1994) A novel inhibitor of cyclin-cdk activity detected in transforming growth factor β-arrested epithelial cells. Mol Cell Biol 14: 3683-3694
95. Smith M, Chen I, Zhan Q, Bae I, Chen C, Gilmer T, Kastan M, OConnor P, Fornace A (1994) Interaction of the p53-regulated protein GADD45 with proliferating cell nuclear antigen Science 266. 1376-1380
96. Stewart N, Hicks GG, Paraskevas F, Mowat M (1995) Evidence for a second cell cycle block at G2/M by p53. Oncogene 10 109-115
97. Strasser A, Harris A, Bath M, Cory S (1990) Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature 348: 331-333
98. Telford WG, King LE, Fraker PJ (1991) Evaluation of glucocorticoid-induced DNA fragmentation in mouse thymocytes by flow cytometry. Cell Prolif 24 447-459
99. Toyoshima H, Hunter T (1994) p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 78: 67-74
100. Wang J, Chenivesse X, Henglein B, Brechot C (1990) Hepatitis B virus integration in a cyclin A gene in a hepatocellutar carcinoma. Nature 343:555-557
101. Weaverfeldhaus J, Guirs N, Neuhausen S, Lepaslier D, Stockert E, Skolnick M, Kamb A (1994) Localization of a putative tumor-suppressor gene by using homozysgous deletions in melanomas. Proc Natl Acad Sci USA 1994: 7563-7567
102. Weinert TA, Hartwell LH (1988) The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. Science 241: 317-322
103. White E (1993) Regulation of apoptosis by the transforming genes of the DNA tumor virus adenovirus. PSEBM 204: 30-39
104. White E (1994) P53, guardian of rb Nature 371: 21-22
105. Xiong Y, Zhang H, Beach D (1993) Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation Genes Dev 7: 1572-1583
106. Xu M, Sheppard K-A, Peng C-Y, Yee A, Piwnica-Worms H (1994) Cyclin A/CDK2binds directly to E2F-1 and inhibits the the N-binding activity of E2F-1/DP-1 by phosphorylation. Mol Cell Biol 14. 8420-8431
107. Yamada T, Ohyama H (1988) Radiation-induced interphase death of rat thymocytes is internally programmed (apoptosis). Int J Radiat Biol 53: 65-75
108. Zeigler A, Jonason A, Leffell D, Simon J, Sharma H, Kimmelman J, Remington L, Jacks T, Brash D (1994) Sunburn and p53 in the onset of skin cancer. Nature 372 773-776
109. Zeigler A, Leffell D, Kunala S, Sharma H, Gailani M, Simon J, Halgerin A, Baden H, Shapiro P, Bale A, Brash D (1993) Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci USA 90: 4216-4220
110. Zhang H, Hannon G, Beach D (1994) p21-containing cyclin kinases exist in both active and inactive states. Genes Dev 8: 1750-1758